Furthermore, it plays a role in energy production in the body and may promote eye health
Reports from Patients Patient reports outside of clinical settings also support the connection between semaglutide and bloating
It helps by increasing your metabolism, building lean muscle, improving how your body handles insulin, and aiding in long-term weight management
The range is wide because starting weight, metabolic health, diet quality, and activity level all influence the rate
Common gastrointestinal effects reported with GLP-1 therapy include: Nausea (commonly reported, especially during dose escalation) Constipation or diarrhoea Abdominal discomfort or bloating Reduced appetite and early satiety Regarding bowel movement colour specifically, changes in stool colour are not listed as adverse effects in UK SmPCs for GLP-1 receptor agonists